Complex of C60 fullerene with doxorubicin as promising agent in antitumor therapy

Dr. Rostyslav Panchuk, Institute of Cell Biology NAS of Ukraine

Video was recorded during the 3rd International research and practice Conference "Nanotechnology and Nanomaterials", Lviv, August 2015.

The purpose of this work was to evaluate the effect of C60 fullerene with antitumor drug doxorubicin (C60+Dox) complex on the growth and metastasis of Lewis lung carcinoma and to perform a primary screening of the potential mechanisms of C60+Dox complex action. The volume of tumor from male С57Bl/6 mice treated with the C60+Dox complex was 1.4 times less than that in control untreated animals. The number of metastatic foci in animal lungs from the group treated with C60+Dox complex was 2 times less than that in control untreated animals. Western blot analysis of tumor lysates revealed significantly decreased level of heat-shock protein 70 in animals treated with C60+Dox complex. Moreover, the treatment of tumor-bearing mice was accompanied by the increase of cytotoxic activity of immune cells. Thus, the potential mechanisms of C60+Dox complex antitumor effect are direct action on tumor cells by inducing cell death and by increasing of stress sensitivity as well as immunomodulating effect. The obtained results provide scientific basis for further application of C60+Dox nanocomplexes as agents in cancer chemotherapy.